152 related articles for article (PubMed ID: 22185025)
41. [Relationship between hyperuricemia and metabolic syndrome].
Yamasaki T; Tomita K
Nihon Rinsho; 2008 Apr; 66(4):766-70. PubMed ID: 18409529
[TBL] [Abstract][Full Text] [Related]
42. Hypertension, its treatment, hyperuricaemia and gout.
Gibson TJ
Curr Opin Rheumatol; 2013 Mar; 25(2):217-22. PubMed ID: 23370375
[TBL] [Abstract][Full Text] [Related]
43. The conundrum of hyperuricemia, metabolic syndrome, and renal disease.
Nakagawa T; Cirillo P; Sato W; Gersch M; Sautin Y; Roncal C; Mu W; Sánchez-Lozada LG; Johnson RJ
Intern Emerg Med; 2008 Dec; 3(4):313-8. PubMed ID: 18320146
[TBL] [Abstract][Full Text] [Related]
44. Uricaemia and left ventricular mass in hypertensive patients.
Catena C; Colussi G; Capobianco F; Brosolo G; Sechi LA
Eur J Clin Invest; 2014 Oct; 44(10):972-81. PubMed ID: 25186106
[TBL] [Abstract][Full Text] [Related]
45. Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients.
Hamada T; Mizuta E; Kondo T; Hirai M; Yamada K; Kato M; Shigemasa C; Yamamoto Y; Ninomiya H; Igawa O; Hisatome I
Arzneimittelforschung; 2010; 60(2):71-5. PubMed ID: 20329654
[TBL] [Abstract][Full Text] [Related]
46. Part 1. Uric acid and losartan.
Sica DA; Schoolwerth AC
Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):475-82. PubMed ID: 12187310
[TBL] [Abstract][Full Text] [Related]
47. [Hyperuricemia and uro-nephrological disorders].
Hurtes X; Meria P
Presse Med; 2011 Sep; 40(9 Pt 1):865-8. PubMed ID: 21684106
[TBL] [Abstract][Full Text] [Related]
48. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
49. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.
Talaat KM; el-Sheikh AR
Am J Nephrol; 2007; 27(5):435-40. PubMed ID: 17622758
[TBL] [Abstract][Full Text] [Related]
50. The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia.
Wu L; Fan Y; Wang Y; Li Z; Mao D; Zhuang W
J Clin Lab Anal; 2021 Oct; 35(10):e23949. PubMed ID: 34498315
[TBL] [Abstract][Full Text] [Related]
51. Serum uric acid as prognostic marker of coronary heart disease (CHD).
Purnima S; El-Aal BG
Clin Investig Arterioscler; 2016; 28(5):216-224. PubMed ID: 27663421
[TBL] [Abstract][Full Text] [Related]
52. Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients.
Chida R; Hisauchi I; Toyoda S; Kikuchi M; Komatsu T; Hori Y; Nakahara S; Sakai Y; Inoue T; Taguchi I
Hypertens Res; 2015 Nov; 38(11):765-9. PubMed ID: 26178150
[TBL] [Abstract][Full Text] [Related]
53. Is there anything good in uric acid?
Alvarez-Lario B; Macarrón-Vicente J
QJM; 2011 Dec; 104(12):1015-24. PubMed ID: 21908382
[TBL] [Abstract][Full Text] [Related]
54. Losartan alleviates hyperuricemia-induced atherosclerosis in a rabbit model.
Zheng H; Li N; Ding Y; Miao P
Int J Clin Exp Pathol; 2015; 8(9):10428-35. PubMed ID: 26617751
[TBL] [Abstract][Full Text] [Related]
55. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
56. Beneficial effect of switching from a combination of angiotensin II receptor blockers other than losartan and thiazides to a fixed dose of losartan/hydrochlorothiazide on uric acid metabolism in hypertensive patients.
Ohshiro K; Sakima A; Nakada S; Kohagura K; Yamazato M; Tana T; Ohya Y
Clin Exp Hypertens; 2011; 33(8):565-70. PubMed ID: 21958001
[TBL] [Abstract][Full Text] [Related]
57. Hypertensive treatment in patients with metabolic syndrome.
Siegel D; Swislocki AL
Metab Syndr Relat Disord; 2010 Apr; 8(2):95-104. PubMed ID: 20156078
[TBL] [Abstract][Full Text] [Related]
58. Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia.
Ohta Y; Ishizuka A; Arima H; Hayashi S; Iwashima Y; Kishida M; Yoshihara F; Nakamura S; Kawano Y
Hypertens Res; 2017 Mar; 40(3):259-263. PubMed ID: 27760998
[TBL] [Abstract][Full Text] [Related]
59. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
Abe M; Okada K; Matsumoto K
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
[TBL] [Abstract][Full Text] [Related]
60. Hyperuricemia and Gout: The Role of Losartan.
Saad M
Sr Care Pharm; 2023 Sep; 38(9):359-360. PubMed ID: 37612850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
